Drug intelligence / Profile preview

Manyanshuning

Development stage: Unknown
Lead developer: Reckitt
Administration: Oral

Overview

Manyanshuning (慢严舒柠) is a prominent brand and product line of traditional Chinese medicine (TCM) and over-the-counter (OTC) throat care products developed by Gui Long Pharmaceutical. The product line includes flagship formulations such as Manyanshuning Qinghou Liyan Keli (清喉利咽颗粒) and Manyanshuning Yanyanpian (咽炎片). These products are formulated with a blend of traditional Chinese herbs, including Scutellaria baicalensis (黄芩), Terminalia chebula (西青果), Platycodon grandiflorus (桔梗), and Ophiopogon japonicus (麦冬), which work synergistically to clear heat, detoxify, moisten the throat, and relieve cough and itching. Manyanshuning is widely used in China for the symptomatic relief of sore throat, throat dryness, hoarseness, and chronic pharyngitis.

Brand names: Manyanshuning
Other names: 慢严舒柠

Beyond the preview

Go deeper on Manyanshuning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Manyanshuning.

Explore the full profile